Ischemic Heart Disease
410
52
76
199
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
34 trials with published results (8%)
Research Maturity
199 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.1%
21 terminated out of 410 trials
90.5%
+3.9% vs benchmark
13%
53 trials in Phase 3/4
17%
34 of 199 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 199 completed trials
Clinical Trials (410)
Longitudinal Validation of CIRC Technologies
Functional ComprEhensive AssessmenT by IVUS Reconstruction in Patients With Suspected IschEmic Heart Disease (FEATURE)
Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coordination
Treatment of Functionally Non-significant Vulnerable Plaques in Patients With Multivessel ST-elevation Myocardial Infarction The VULNERABLE Trial
Sequent Extended Study
Role Of Fixed Prosthodontic Restorations on Metabolic Control of Ischemic Heart Disease Patients
Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS
Optical Coherence Tomography in Acute Vessel Evaluation
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System
QFR-Guided Virtual Stenting for Preprocedural Physiological Optimization of Percutaneous Coronary Intervention: A Randomized Controlled Trial
Polyamine Treatment in Elderly Patients With Coronary Artery Disease
LONG NAGOMI™ PMCF STUDY
Predicting the Risk of Non-culprit Coronary Artery Disease After a Heart Attack
Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation
Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)
Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABG
Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor